Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma

[1]  M. Weller,et al.  Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma , 2020, JAMA oncology.

[2]  Versione,et al.  Common Terminology Criteria for Adverse Events , 2020, Definitions.

[3]  Jill S Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. , 2018, Neuro-oncology.

[4]  M. Shamim,et al.  The significance of MGMT methylation in Glioblastoma Multiforme prognosis. , 2018, JPMA. The Journal of the Pakistan Medical Association.

[5]  M. Mrugala,et al.  Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice. , 2017, Neuro-oncology practice.

[6]  Martin Klein,et al.  Lomustine and Bevacizumab in Progressive Glioblastoma , 2017, The New England journal of medicine.

[7]  Inamullah Khan,et al.  Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme. , 2017, JPMA. The Journal of the Pakistan Medical Association.

[8]  Erich P Huang,et al.  RECIST 1.1-Update and clarification: From the RECIST committee. , 2016, European journal of cancer.

[9]  H. Seol,et al.  Outcome of salvage treatment for recurrent glioblastoma , 2015, Journal of Clinical Neuroscience.

[10]  T. Mesti,et al.  Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience , 2015, Radiology and oncology.

[11]  J. Carlson,et al.  Clinical Clinical outcomes following salvage Gamma Knife radiosurgery for recurrent glioblastoma , 2014 .

[12]  Matthew J. Oborski,et al.  Cancer Management and Research Dovepress Malignant Gliomas: Current Perspectives in Diagnosis, Treatment, and Early Response Assessment Using Advanced Quantitative Imaging Methods , 2022 .

[13]  K. Aldape,et al.  A randomized trial of bevacizumab for newly diagnosed glioblastoma. , 2014, The New England journal of medicine.

[14]  Nina Kočevar,et al.  Glioma and glioblastoma - how much do we (not) know? , 2013, Molecular and clinical oncology.

[15]  W. Curran,et al.  RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients. , 2013, International journal of radiation oncology, biology, physics.

[16]  D. Kondziolka,et al.  Salvage gamma knife stereotactic radiosurgery followed by bevacizumab for recurrent glioblastoma multiforme: a case–control study , 2012, Journal of Neuro-Oncology.

[17]  A. Kyritsis,et al.  An algorithm for chemotherapy treatment of recurrent glioma patients after temozolomide failure in the general oncology setting , 2011, Cancer Chemotherapy and Pharmacology.

[18]  Raymond Sawaya,et al.  Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Susan M. Chang,et al.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Mikkelsen,et al.  Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  John A Butman,et al.  Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Lawrence B Marks,et al.  The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. , 2008, Seminars in radiation oncology.

[23]  Jung-Il Lee,et al.  Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas , 2008, Cancer.

[24]  E. Perez,et al.  Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. , 2007, The New England journal of medicine.

[25]  John Sampson,et al.  Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[27]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[28]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[29]  David M Jablons,et al.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Seth M Steinberg,et al.  A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.

[31]  P Van Tassel,et al.  Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. , 2000, Radiology.

[32]  D. Silbergeld,et al.  Isolation and characterization of human malignant glioma cells from histologically normal brain. , 1997, Journal of neurosurgery.

[33]  D. Moody,et al.  MRI of radiation injury to the brain. , 1986, AJR. American journal of roentgenology.

[34]  Kahkashan Perveen,et al.  Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment , 2017, Asian Pacific journal of cancer prevention : APJCP.

[35]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[36]  M. Prados,et al.  Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. , 1994, International journal of radiation oncology, biology, physics.